{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T20:06:37Z","timestamp":1770235597059,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2456,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.jacc.2006.08.031","type":"journal-article","created":{"date-parts":[[2006,11,10]],"date-time":"2006-11-10T12:28:04Z","timestamp":1163161684000},"page":"2161-2167","source":"Crossref","is-referenced-by-count":141,"title":["Protective Effects of Erythropoietin in Cardiac Ischemia"],"prefix":"10.1016","volume":"48","author":[{"given":"Erik","family":"Lip\u0161ic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regien G.","family":"Schoemaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriaan A.","family":"Voors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk J.","family":"van Veldhuisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiek H.","family":"van Gilst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2006.08.031_bib1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1001\/archinte.164.3.262","article-title":"Epoetin alfa","volume":"164","author":"Henry","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2006.08.031_bib2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00277-004-0911-6","article-title":"Beneficial and ominous aspects of the pleiotropic action of erythropoietin","volume":"83","author":"Jelkmann","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jacc.2006.08.031_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2141.2001.03058.x","article-title":"Biological significance of MAPK, AKT and JAK-STAT protein activation by various erythropoietic factors in normal human early erythroid cells","volume":"115","author":"Ratajczak","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jacc.2006.08.031_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/153537020322800101","article-title":"Erythropoietin: physiology and pharmacology update","volume":"228","author":"Fisher","year":"2003","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.jacc.2006.08.031_bib5","doi-asserted-by":"crossref","first-page":"7580","DOI":"10.1073\/pnas.82.22.7580","article-title":"Cloning and expression of the human erythropoietin gene","volume":"82","author":"Lin","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2006.08.031_bib6","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.ejca.2004.07.015","article-title":"EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer","volume":"40","author":"Bokemeyer","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jacc.2006.08.031_bib7","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1073\/pnas.97.19.10526","article-title":"Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury","volume":"97","author":"Brines","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2006.08.031_bib8","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1523-1755.2004.00847.x","article-title":"Pretreatment with EPO reduces the injury and dysfunction caused by ischemia\/reperfusion in the mouse kidney in vivo","volume":"66","author":"Patel","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2006.08.031_bib9","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nm723","article-title":"HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration","volume":"8","author":"Grimm","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2006.08.031_bib10","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/sj.bjp.0702521","article-title":"Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock","volume":"127","author":"Squadrito","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacc.2006.08.031_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/01.CIR.0000078635.89229.8A","article-title":"Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury","volume":"108","author":"Cai","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2006.08.031_bib12","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1073\/pnas.0630444100","article-title":"Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling","volume":"100","author":"Calvillo","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2006.08.031_bib13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.fjc.0000140209.04675.c3","article-title":"Timing of erythropoietin treatment for cardioprotection in ischemia\/reperfusion","volume":"44","author":"Lipsic","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacc.2006.08.031_bib14","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1172\/JCI18200","article-title":"A novel protective effect of erythropoietin in the infarcted heart","volume":"112","author":"Parsa","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2006.08.031_bib15","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1073\/pnas.91.9.3974","article-title":"Erythropoietin receptor mRNA expression in human endothelial cells","volume":"91","author":"Anagnostou","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2006.08.031_bib16","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1161\/01.CIR.0000039103.58920.1F","article-title":"Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases","volume":"106","author":"Chong","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2006.08.031_bib17","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0006-291X(03)01503-1","article-title":"Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway","volume":"308","author":"Tramontano","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacc.2006.08.031_bib18","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1096\/fj.03-1289fje","article-title":"Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury","volume":"18","author":"Wright","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.jacc.2006.08.031_bib19","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ejheart.2004.03.012","article-title":"Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury","volume":"6","author":"van der Meer","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2006.08.031_bib20","doi-asserted-by":"crossref","first-page":"877.e1","DOI":"10.1016\/j.jtcvs.2004.12.041","article-title":"Expression of the erythropoietin receptor in human heart","volume":"130","author":"Depping","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2006.08.031_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.1098313","article-title":"Derivatives of erythropoietin that are tissue protective but not erythropoietic","volume":"305","author":"Leist","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jacc.2006.08.031_bib22","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1073\/pnas.0406491101","article-title":"Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor","volume":"101","author":"Brines","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2006.08.031_bib23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/078538902321012414","article-title":"Apoptosis in myocardial infarction","volume":"34","author":"Rodriguez","year":"2002","journal-title":"Ann Med"},{"key":"10.1016\/j.jacc.2006.08.031_bib24","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1161\/01.CIR.0000127954.98131.23","article-title":"Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia\/reperfusion injury","volume":"109","author":"Cai","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2006.08.031_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00395-004-0455-x","article-title":"Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels","volume":"99","author":"Shi","year":"2004","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacc.2006.08.031_bib26","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1096\/fj.04-3545fje","article-title":"Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling","volume":"19","author":"Hanlon","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.jacc.2006.08.031_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00395-005-0537-4","article-title":"Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo","volume":"100","author":"Bullard","year":"2005","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacc.2006.08.031_bib28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cardiores.2004.11.019","article-title":"Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia\/reperfusion via induction of AP-1","volume":"65","author":"Rui","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2006.08.031_bib29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000188711","article-title":"Erythropoietin modified the cardiac action of ouabain in chronically anaemic-uraemic rats","volume":"71","author":"Wald","year":"1995","journal-title":"Nephron"},{"key":"10.1016\/j.jacc.2006.08.031_bib30","first-page":"1162","article-title":"Erythropoietin stimulates atrial natriuretic peptide secretion from adult rat cardiac atrium","volume":"276","author":"Porat","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jacc.2006.08.031_bib31","doi-asserted-by":"crossref","first-page":"20655","DOI":"10.1074\/jbc.M314099200","article-title":"Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts","volume":"279","author":"Parsa","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacc.2006.08.031_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10557-005-6895-1","article-title":"Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts","volume":"19","author":"Hirata","year":"2005","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2006.08.031_bib33","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.0409329102","article-title":"A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury","volume":"102","author":"Fiordaliso","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2006.08.031_bib34","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1073\/pnas.1930406100","article-title":"Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats","volume":"100","author":"Moon","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2006.08.031_bib35","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nature02446","article-title":"Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts","volume":"428","author":"Murry","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2006.08.031_bib36","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1161\/hc2301.092122","article-title":"Mobilization of endothelial progenitor cells in patients with acute myocardial infarction","volume":"103","author":"Shintani","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2006.08.031_bib37","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa043814","article-title":"Circulating endothelial progenitor cells and cardiovascular outcomes","volume":"353","author":"Werner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2006.08.031_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(04)16626-9","article-title":"Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial","volume":"364","author":"Wollert","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2006.08.031_bib39","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/CIRCULATIONAHA.105.575118","article-title":"Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months\u2019 follow-up data from the randomized, controlled BOOST (bone marrow transfer to enhance ST-elevation infarct regeneration) trial","volume":"113","author":"Meyer","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2006.08.031_bib40","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1182\/blood-2003-01-0223","article-title":"Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization","volume":"102","author":"Heeschen","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2006.08.031_bib41","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1161\/01.STR.0000132196.49028.a4","article-title":"Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats","volume":"35","author":"Wang","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2006.08.031_bib42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jacc.2005.03.044","article-title":"Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction","volume":"46","author":"van der Meer","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2006.08.031_bib43","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1182\/blood-2003-04-1284","article-title":"Erythropoietin regulates endothelial progenitor cells","volume":"103","author":"Bahlmann","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2006.08.031_bib44","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood.V93.8.2627","article-title":"Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo","volume":"93","author":"Ribatti","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2006.08.031_bib45","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1006\/mvre.2002.2426","article-title":"Erythropoietin and VEGF exhibit equal angiogenic potential","volume":"64","author":"Jaquet","year":"2002","journal-title":"Microvasc Res"},{"key":"10.1016\/j.jacc.2006.08.031_bib46","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2006.08.031_bib47","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/01.CIR.0000139335.04152.F3","article-title":"Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure","volume":"110","author":"Bahlmann","year":"2004","journal-title":"Circulation"},{"issue":"Suppl A","key":"10.1016\/j.jacc.2006.08.031_bib48","first-page":"74A","article-title":"Low-dose erythropoietin treatment preserves cardiac function and mobilizes endothelial progenitor cells in rats with ischemic heart failure","volume":"47","author":"Lipsic","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2006.08.031_bib49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-6386(96)90130-4","article-title":"The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease","volume":"28","author":"Foley","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2006.08.031_bib50","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1523-1755.2005.00458.x","article-title":"Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10 g\/dL","volume":"68","author":"Ayus","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2006.08.031_bib51","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/ndt\/15.9.1425","article-title":"Effects of haemoglobin normalization on quality of life and cardiovascular parameters in end-stage renal failure","volume":"15","author":"McMahon","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2006.08.031_bib52","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ahj.2004.09.047","article-title":"Rationale\u2014Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease","volume":"149","author":"Mix","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2006.08.031_bib53","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ehj.2003.11.017","article-title":"Erythropoietin in cardiovascular diseases","volume":"25","author":"van der Meer","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2006.08.031_bib54","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1093\/eurheartj\/ehi388","article-title":"Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure","volume":"26","author":"Opasich","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2006.08.031_bib55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jacc.2004.03.052","article-title":"Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure","volume":"44","author":"van der Meer","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2006.08.031_bib56","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1161\/CIRCULATIONAHA.105.549121","article-title":"Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure","volume":"112","author":"van der Meer","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2006.08.031_bib57","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0735-1097(01)01248-7","article-title":"The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study","volume":"37","author":"Silverberg","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2006.08.031_bib58","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.CIR.0000044914.42696.6A","article-title":"Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure","volume":"107","author":"Mancini","year":"2003","journal-title":"Circulation"},{"issue":"Suppl A","key":"10.1016\/j.jacc.2006.08.031_bib59","first-page":"61A","article-title":"Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa on hemoglobin response and symptoms in patients with heart failure and anemia","volume":"47","author":"van Veldhuisen","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2006.08.031_bib60","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jacc.2005.01.043","article-title":"High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention","volume":"45","author":"Namiuchi","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2006.08.031_bib61","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10557-006-7680-5","article-title":"A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study","volume":"20","author":"Lipsic","year":"2006","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109706023333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109706023333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T00:02:54Z","timestamp":1587254574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109706023333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":61,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0735109706023333"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2006.08.031","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}